American International Group, Inc. Celldex Therapeutics, Inc. Transaction History

American International Group, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$35.22 - $51.88 $265,382 - $390,915	7,535 Added 32.63%	30,629 $1.29 Million
Q4 2023 Feb 13, 2024	SELL	$22.61 - $40.65 $2,102 - $3,780	-93 Reduced 0.4%	23,094 $915,000
Q3 2023 Nov 13, 2023	BUY	$25.45 - $37.46 $20,970 - $30,867	824 Added 3.68%	23,187 $638,000
Q2 2023 Aug 04, 2023	BUY	$30.29 - $38.28 $7,421 - $9,378	245 Added 1.11%	22,363 $758,000
Q1 2023 May 12, 2023	BUY	$34.78 - $47.43 $15,337 - $20,916	441 Added 2.03%	22,118 $795,000
Q4 2022 Feb 10, 2023	SELL	$27.78 - $45.38 $2,194 - $3,585	-79 Reduced 0.36%	21,677 $966,000
Q3 2022 Nov 14, 2022	BUY	$22.7 - $37.57 $6,968 - $11,533	307 Added 1.43%	21,756 $612,000
Q2 2022 Aug 12, 2022	SELL	$20.5 - $37.33 $28,331 - $51,590	-1,382 Reduced 6.05%	21,449 $578,000
Q1 2022 May 13, 2022	SELL	$27.64 - $39.32 $44,417 - $63,187	-1,607 Reduced 6.58%	22,831 $778,000
Q4 2021 Feb 11, 2022	SELL	$35.68 - $56.27 $26,082 - $41,133	-731 Reduced 2.9%	24,438 $944,000
Q3 2021 Nov 12, 2021	BUY	$28.95 - $55.99 $92,611 - $179,112	3,199 Added 14.56%	25,169 $1.36 Million
Q2 2021 Aug 13, 2021	BUY	$20.71 - $35.37 $454,998 - $777,078	21,970 New	21,970 $735,000

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.1B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.